These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7502817)

  • 1. The interaction of gliadin with effector and target cells in NK cell activity of patients with celiac disease.
    Nguyen HH; Farré MA; Tlaskalová H; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1359-62. PubMed ID: 7502817
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct gliadin cytotoxicity as a cofactor in the pathogenesis of celiac disease.
    Elli L; Dolfini E; Bardella MT
    Int Arch Allergy Immunol; 2004 May; 134(1):88. PubMed ID: 15133305
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel mechanisms of gliadin immunotoxicity?
    Arranz E; Garrote JA
    Gut; 2010 Mar; 59(3):286-7. PubMed ID: 20207631
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune reactions induced by gliadin.
    Tlaskalová-Hogenová H; Stepánkova R; Tucková L; Farre MA; Vetvicka V; Trávnicek J; Kolínská J; Kocna P; Fric P; Holub M
    Adv Exp Med Biol; 1995; 371B():1191-8. PubMed ID: 7502782
    [No Abstract]   [Full Text] [Related]  

  • 5. IgA subclass distribution of IgA anti-gliadin antibodies in feces of patients with coeliac disease.
    Haas L; Petit-Phar M; Terzidis H; Kapel N; Meillet D; Gobert JG; Rostoker G
    Adv Exp Med Biol; 1995; 371B():1349-53. PubMed ID: 7502815
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin.
    Castany MA; Nguyen HH; Pospísil M; Fric P; Tlaskalová-Hogenová H
    Folia Microbiol (Praha); 1995; 40(6):615-20. PubMed ID: 8768253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of natural and synthetic peptides derived from gliadin with different cell lines.
    Farré MA; Tlaskalová H; Nguyen HH; Kocna P; Tucková L; Krchnák V; Vetvicka V; Baudisová M; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1371-3. PubMed ID: 7502820
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro model of the pathogenesis of celiac disease.
    Oberhuber G; Schwarzenhofer M; Vogelsang H
    Dig Dis; 1998; 16(6):341-4. PubMed ID: 10207219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is gliadin harmful from the first morsel?
    Dieterich W; Schuppan D
    Dig Liver Dis; 2007 Oct; 39(10):917-21. PubMed ID: 17720638
    [No Abstract]   [Full Text] [Related]  

  • 10. Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro.
    Ciclitira PJ; Ellis HJ; Wood GM; Howdle PD; Losowsky MS
    Clin Exp Immunol; 1986 Apr; 64(1):119-24. PubMed ID: 3731523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to gliadin within the small-intestinal mucosa in celiac disease.
    Nutr Rev; 1975 Sep; 33(9):267-8. PubMed ID: 1099482
    [No Abstract]   [Full Text] [Related]  

  • 12. Adaptive and innate immune responses in celiac disease.
    Gianfrani C; Auricchio S; Troncone R
    Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of mucosa-specific antibodies against gliadin by a sensitive technique using the biotin-streptavidin system.
    Peña AS; Lems-van Kan PH; Kuiper I; van Duijn W; Lamers CB
    Acta Gastroenterol Belg; 1986; 49(4):423-6. PubMed ID: 3577612
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term cultivation of duodenal biopsies in patients with coeliac disease. Effect of gluten challenge and gliadin peptides.
    Kocna P; Fric P; Tlaskalová H; Krchnák V; Kasafírek E; Síová M; Czerkinsky C
    Adv Exp Med Biol; 1995; 371B():1367-70. PubMed ID: 7502819
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease.
    Vogelsang H; Schwarzenhofer M; Granditsch G; Oberhuber G
    Am J Gastroenterol; 1999 Apr; 94(4):1057-61. PubMed ID: 10201483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current concepts in the pathogenesis of celiac disease].
    Auricchio S
    Wien Klin Wochenschr; 1986 Aug; 98(16):517-20. PubMed ID: 3765639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model for the pathogenesis of celiac disease.
    Biagi F; Parnell ND; Thomas PD; Ellis HJ; Ciclitira PJ
    Gastroenterology; 1999 May; 116(5):1277-8. PubMed ID: 10220531
    [No Abstract]   [Full Text] [Related]  

  • 18. Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.
    Engström PE; Sundin U; Lavö B; Norhagen G; Hällgren R; Smith CI; Hammarström L
    Immunology; 1992 Dec; 77(4):604-8. PubMed ID: 1493932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
    Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies in celiac disease.
    Dieterich W; Storch WB; Schuppan D
    Clin Lab; 2000; 46(7-8):361-4. PubMed ID: 10934583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.